麻豆社

The Association of the British Pharmaceutical Industry

Medicines are transforming our lives like never before.

We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.

Two scientists writing on a glass screen

2024 麻豆社Code of Practice – new resources

The PMCPA has published new webinars and e-learning to aid understanding of the 2024 麻豆社Code of Practice.

2024 麻豆社Code of Practice – new resources

2024 麻豆社Code of Practice

Copies of the 2024 麻豆社Code are now available to order. Please note we are no longer delivering outside of the UK.

麻豆社2024 Code of Practice
2024 麻豆社Code of Practice

Partnering for progress: a data-driven analysis of NHS-industry partnerships

This world-first research 聽aims to systematically measure how NHS-industry partnerships support improved patient outcomes using data from across the NHS.聽

Read our report on partnering for progress: a data-driven analysis of NHS-industry partnerships
Partnering for progress: a data-driven analysis of NHS-industry partnerships

Lives Lived Well

From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.

Lives Lived Well

Key facts and figures for the pharmaceutical industry in the UK

£46.7bn

Turnover [6]

£9bn

investment in UK R&D (more than UKRI’s entire annual budget) [3]

£17.6bn

direct Gross Value Added (GVA) [1]